TransCode Therapeutics, Inc. Announces $8 Million Private Placement
27 nov. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
17 sept. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
Biobanking Market revenue to surpass USD 90 Billion by 2033, says Research Nester
08 févr. 2024 05h00 HE
|
Research Nester
New York, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The global biobanking market size is projected to expand at ~8% CAGR between 2023 and 2033. The market is expected to garner a revenue of USD 90 billion...
Multiplex Detection Immunoassays Market Revenue to Cross USD 3.6 billion by 2030, Rising at a 7.5% CAGR: TMR Report
20 sept. 2023 09h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The multiplex detection immunoassays market was estimated to have acquired US$ 1.5 billion...
Rising Cases of Chronic Disease among Elderly Population to Foster the Growth of the Global Multiplex Assay Market by 2028 – Exclusive Report [288 Pages] By Research Dive
23 août 2021 09h00 HE
|
Research Dive
New York, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Research Dive states that the global multiplex assay market is anticipated to register a revenue of $4,162.5 million by 2028, at a CAGR of 5.8% during the...
Global Multiplex Assay Market Expected to Rise at a CAGR of 5.8% and Surpass $4,162.5 Million from 2021 to 2028 – Exclusive Report [288 Pages] By Research Dive
20 juil. 2021 09h06 HE
|
Research Dive
New York, USA, July 20, 2021 (GLOBE NEWSWIRE) -- According to Research Dive, the global multiplex assay market is estimated to generate a revenue of $4,162.5 million by 2028, and grow at CAGR of...
Gennao Bio Appoints Chris Duke as Chief Operating Officer and Julie Hambleton, M.D., to Board of Directors
13 juil. 2021 07h30 HE
|
Gennao Bio
HOPEWELL, N.J., July 13, 2021 (GLOBE NEWSWIRE) -- Gennao Bio, a privately held genetic medicines company developing first-in-class, targeted nucleic acid therapeutics, today announced the...
Celsion Corporation Appoints Dr. Stacy R. Lindborg to its Board of Directors
08 juin 2021 08h00 HE
|
Celsion CORP
25-year pharmaceutical industry executive brings broad drug development perspective Replaces Alberto Martinez, MD LAWRENCEVILLE, N.J., June 08, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation...
Gennao Bio Closes $40 Million Series A Financing to Develop Pipeline of Targeted Nucleic Acid Therapeutics
10 mai 2021 08h30 HE
|
Gennao Bio
~ Financing Co-led by OrbiMed and Logos Capital to Support Advancement of Proprietary Gene Monoclonal Antibody Platform (GMAB) ~ ~ Stephen Squinto, Ph.D., Appointed Chief Executive Officer and...
Nucleic Acid Isolation and Purification Market Value Predicted To Reach US$ 7,623.6 Million By 2027 Covering Pre and Post COVID-19 Market Analysis: Acumen Research and Consulting
19 avr. 2021 11h09 HE
|
Acumen Research and Consulting
LOS ANGELES, April 19, 2021 (GLOBE NEWSWIRE) -- The Global Nucleic Acid Isolation and Purification Market is expected to grow at a CAGR of around 8.8% from 2020 to 2027 and reach the market value of...